This release is a segment of a full release published here.
Uniting Local and Global Expertise to Address Healthcare Challenges and Foster Innovation
In a significant step towards revolutionizing Brazil’s healthcare landscape, a new Partnership for Productive Development (PDP) has been announced. This initiative aims to strengthen domestic production of active pharmaceutical ingredients (APIs) and finished medicines, addressing critical healthcare challenges.
The ambitious partnership unites Of Joseph PB&T, the Peixe Rosa Program, the Therapeutic Innovation Research Center – Suely Galdino (NUPIT-SG) of the Federal University of Pernambuco (UFPE), with technological contributions from the Indian pharmaceutical industry. Additionally, UNI Pharma API Corp, a U.S.-based investment group, will provide financial backing and support U.S. distribution of excess Brazilian-sourced APIs for finished drug production.
Initially focusing on vital leukemia treatments for the Unified Health System (SUS), the project is poised to invest R$84 million in its first phase. This marks a major milestone in advancing the Ministry of Health’s goal to secure robust domestic API manufacturing. Over the next year, three additional PDP initiatives are planned to enhance Brazil’s biotech industrial sector through technology transfer and public investment support.
By combining financial expertise, research capabilities, and technological leadership, the collaboration seeks to reduce Brazil’s dependence on foreign suppliers while positioning the nation as a leader in pharmaceutical production and innovation.
Cite: Brazil Press on University Initiative to Produce API
Full Gallery: UNI Venture Group Founder, Nathan BenAmoz during his trip to CPHI India.
